Drugmaker Vectura's first-half revenue up 6 percent on rising sales of inhaled products

Vectura said revenue rose 6 percent in the first half of the year, driven by rising sales of its recently launched inhaled products and the continued weakness of sterling against a basket of its main trading currencies.